SGMT

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for metabolic dysfunction-associated steatohepatitis and other metabolic diseases. The company uses novel therapeutic approaches targeting fatty acid metabolism. Sagimet is advancing multiple drug candidates through clinical trials.